Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,109,327 papers from all fields of science
Search
Sign In
Create Free Account
NCKAP5 gene
Known as:
ERIH1
, NCK associated protein 5
, NCK-ASSOCIATED PROTEIN 5
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Red plunger syringes for neuromuscular blocking drugs
D. Rowe
Anaesthesia
2015
Corpus ID: 207005152
Review
2015
Review
2015
NAP 5 : aware of the limitations
P. Ward
,
Hong Kong.
,
I. Yildiz
2015
Corpus ID: 92980796
Editor—I would like to congratulate P.S. Myles on an excellent editorial in the BJA, and reiterate the caution he expresses…
Expand
Review
2014
Review
2014
Who operates when, where and on whom? A survey of anaesthetic‐surgical activity in Ireland as denominator of NAP5
W. R. Jonker
,
D. Hanumanthiah
,
T. Ryan
,
T. Cook
,
J. Pandit
,
E. O’Sullivan
Anaesthesia
2014
Corpus ID: 21422251
The second phase of the 5th National Audit Project of the Royal College of Anaesthetists and the Association of Anaesthetists of…
Expand
2013
2013
NAP5 and awareness under anaesthesia: prevention is not the complete solution
P. Bhalla
,
M. Sacks
,
M. Kenny
,
Georgina Smith
,
V. Krishnamoorthy
2013
Corpus ID: 79400716
2009
2009
Acid Resistance Influences Sensitivity to Ionizing Radiation among Salmonella Isolatest
Brendan A. Njf
2009
Corpus ID: 26216019
Nalidixic acid (Nal) resistance has been used as a selective marker for studies of pathogen-inoculated fruits and vegetables. A…
Expand
2000
2000
Novel, potent and selective chimeric FXa inhibitors featuring hydrophobic P1-ketoamide moieties.
J. Semple
,
O. Levy
,
N. K. Minami
,
T. D. Owens
,
D. V. Siev
Bioorganic & Medicinal Chemistry Letters
2000
Corpus ID: 38319237
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE